Sber Farm Monitor

Main articles:

• Big Data
• Big Data in Medicine
• Data mining Intelligent data analysis
• Business Intelligence Definition]

2021: Release Sber Farm Monitor

On October 29, 2021, SberAnalytics, an ecosystem company, Sbera introduced Pharmaceutical Monitor"," a product based on big data studies of buyers of medicines, dietary supplements and other pharmaceutical assortments. It allows you to make a portrait of the buyer of the drug and its analogues, see the directions of the influx and outflow of the audience between the drugs and find out the top joint purchases with the studied brand or product position (SKU). Segmentation parameters can be traditional (gender, age, level of income or expenditure), and are formed specifically for the market. For example, you can distinguish the category of buyers with children, car owners, lovers coffee or fast food, as well as people who lead an active lifestyle. The product capabilities also include the analytics number of single buyers, the frequency of purchases and the average check.

Illustration: www.zen.yandex.ru

So, thanks to Farm Monitor, SberAnalytics revealed trends in the pharmacy market in the first half of 2021.

It is noted that the volume of sales the pharmacy assortment has practically not changed compared to the same period of 2020 year: 629 billion rubles in January-June 2021 year against 631 billion rubles for the same period last year. Thus, the pharmacy market managed to consolidate the results of the first half of 2020, when demand was strong against the background of the first wave. COVID

The locomotive of sales growth pharmacies is the older generation 65 +. Purchases in pharmacies of this age group increased by 14% compared to the same period in 2020. Spending by a younger audience (up to 25 years old) also increased by 6%, but their contribution to market growth is insignificant due to the small share of this age group in the total consumption of the pharmacy assortment. The leader among age groups, which, on the contrary, significantly reduced purchases, are buyers of 25‒34 years. They reduced purchases by 6% relative to their consumption in the first half of 2020. The remaining segments show moderate rates of decline.

In terms of segments in terms of consumer spending, growth is observed among buyers with an average level of wealth. Among the wealthiest buyers, on the contrary, there is a decline in activity.

"We believe it is important to offer our customers relevant services that will help them develop their business with savings time and funds. pharmaceutical Market research from SberAnalytics will help companies operating in this segment to better understand the needs of the audience and current trends and, depending on them, adjust their actions and plans for the future, building the most optimal development model, " says Stanislav Kartashov, vice president of Sberbank, director of the Corporate Clients 360 division.

A detailed list of the parameters under study can be seen in the demo report on the product page on the SberAnalytics platform. Analytics is built by analyzing a large array of impersonal data based on the actual financial behavior of drug buyers.